Treysta Medical Technologies Inc. filed a Form D with the Securities and Exchange Commission on 2026-02-17.
Treysta Medical Technologies Inc. filed a Form D notice of an exempt securities offering with the SEC on February 17, 2026. The filing reports $90K sold. Its industry group is Biotechnology. It names Nathan Zarnstorff (Executive Officer, Director), Marcelo Buzzi (Executive Officer, Director) (SEC Form D, February 17, 2026).
Is this your company?
Sell to companies like Treysta Medical Technologies Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-02-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Treysta Medical Technologies Inc.
Free to see. No signup.
More on the people and the money behind Treysta Medical Technologies Inc., from the filings we hold.
Biotechnology raises by companies based in Florida, filed in February 2026, largest first.
Get an email when Treysta Medical Technologies Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Treysta Medical Technologies Inc. raises, hires or launches. No email unless you switch it on.
Watch Treysta Medical Technologies Inc. →Get the full cited report on Treysta Medical Technologies Inc.
What the filing shows about Treysta Medical Technologies Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Treysta Medical Technologies Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Treysta Medical Technologies Inc.'s address as 3733 Northwest 53RD Lane, Gainesille, FL 32653.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Treysta Medical Technologies Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Treysta Medical Technologies Inc. See pricing
Treysta Medical Technologies Inc. is a registered filer with the SEC (CIK 2057780) and has filed since 2025-04-10. 2 filings are on record, the latest on 2026-02-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Treysta Medical Technologies Inc.'s Form D of 2026-02-17 names Nathan Zarnstorff and Marcelo Buzzi as its officers, directors or promoters.
Its new offerings report $183K sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $90K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Proceeds will be used for working capital, which may include normal compensation for executive officers.
Nathan Zarnstorff is named as Executive Officer and Director on the Form D that Treysta Medical Technologies Inc. filed with the SEC on 17 February 2026, one of 2 people that filing names.
Marcelo Buzzi is named as Executive Officer and Director on the Form D that Treysta Medical Technologies Inc. filed with the SEC on 17 February 2026, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2026-02-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Treysta Medical Technologies Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Treysta Medical Technologies Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Treysta Medical Technologies Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Treysta Medical Technologies Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Treysta Medical Technologies Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Treysta Medical Technologies Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/treysta-medical-technologies-inc-form-d-26000001